Cost Effectiveness Research is imperative in countries where evidence of cost effectiveness is essential for market entry of a new pharmaceutical or medical device. In China, health economic value dossier is not required as part of regulatory approval for market entry. However, cost effectiveness benefit is valued in evaluation of price and reimbursement. 

We provide consultation and conduct contracted research for assessment of comparative cost utility, cost burden, and budget impact of specific disease areas or specific medical interventions.

We believe value based health care and view cost effectiveness a component of medical evidence.